¨
Preliminary Proxy Statement
|
¨ Confidential,
For Use of the
|
x Definitive
Proxy Statement
|
Commission Only (as permitted
|
¨
Definitive Additional Materials
|
by Rule 14a-6(e)(2))
|
¨
Soliciting Material Pursuant to Rule 14a-11(c) or Rule
14a-12
|
|
3)
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it was
determined):
|
¨
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which
the offsetting fee was
paid previously. Identify the
previous filing by registration statement
number, or the form or schedule and the date of its
filing.
|
1)
|
Amount
previously paid:
|
2)
|
Form,
Schedule or Registration Statement
No.:
|
3)
|
Filing
Party:
|
4)
|
Date
Filed:
|
By
Order of the Board of Directors
Virginia
Woltosz
Secretary
Lancaster,
California
January
22, 2009
|
Russell
2000
|
S&P
600
|
Simulations
Plus, Inc.
|
||||
8/31/2000
|
537.89
|
135.704
|
223.49
|
138.341
|
0.62
|
100
|
8/31/2001
|
468.56
|
118.213
|
223.04
|
138.063
|
0.3
|
48.39
|
8/31/2002
|
391.57
|
98.789
|
200.255
|
123.959
|
0.38
|
61.29
|
8/31/2003
|
508.87
|
128.383
|
243.425
|
150.681
|
0.64
|
103.23
|
8/31/2004
|
547.93
|
138.237
|
277.222
|
171.601
|
0.82
|
132.26
|
8/31/2005
|
661.51
|
166.892
|
347.42
|
215.054
|
0.85
|
137.10
|
8/31/2006
|
720.53
|
181.8
|
368.82
|
228.3
|
1.1
|
177.42
|
8/31/2007
|
786.53
|
198.43
|
417.61
|
258.50
|
6.68
|
1077.4
|
8/31/2008
|
739.50
|
186.568
|
387.35
|
240.00
|
1.81
|
291.94
|
NAME
|
AGE
|
POSITION
WITH THE COMPANY
|
DIRECTOR
SINCE
|
||||
Walter
S. Woltosz
|
63 |
Chairman
of the Board, Chief Executive Officer and President of the
Company.
|
1996
|
||||
Virginia
E. Woltosz
|
57 |
Secretary
and Director of the Company
|
1996
|
||||
Dr.
David Z. D'Argenio
|
59 |
Director
|
1997
|
||||
Dr.
Richard R. Weiss
|
75 |
Director
|
1997
|
||||
Wayne
Rosenberger
|
68 |
Director
|
2007
|
NAME
|
AGE
|
POSITION
WITH THE COMPANY
|
OFFICER
SINCE
|
||||
Momoko
A. Beran
|
56
|
Chief
Financial Officer of the Company and Words+,
Inc.
|
1996
|
||||
Ronald
F. Creeley
|
57
|
Vice
President, Marketing and Sales of the Company
|
1997
|
||||
Jeffrey
A. Dahlen
|
47
|
President
of Words+, Inc.
|
2003
|
Name
and Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-equity
incentive
plan
compensation
($)
|
Changes
in
pension
value
and
nonqualified
deferred
compensation
on
earnings
($)
|
All
Other
Compensation
($)
|
Total
($)
|
|||||||||||||||||||||||||
(a)
|
(b)
|
(d)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i)
|
(j)
|
|||||||||||||||||||||||||
Walter
S. Woltosz
|
2008
|
250,000 | 0 | 0 | - | 0 | 0 | 0 | 250,000 | |||||||||||||||||||||||||
Chief
Executive Officer
|
2007
|
172,000 | 146,289 | 0 | 0 | 0 | 0 | 2,293 | 320,582 | |||||||||||||||||||||||||
2006
|
172,000 | 49,887 | 0 | 0 | 0 | 0 | 2,580 | 236,887 | ||||||||||||||||||||||||||
Momoko
A. Beran
|
2008
|
125,000 | 14,308 | 0 | 22,727 | 0 | 0 | 5,000 | 162,035 | |||||||||||||||||||||||||
Chief
Financial Officer
|
2007
|
120,000 | 6,640 | 0 | - | 0 | 0 | 4,800 | 131,400 | |||||||||||||||||||||||||
2006
|
100,000 | 3,332 | 0 | 0 | 0 | 0 | 4,360 | 107,692 | ||||||||||||||||||||||||||
Ronald
F. Creeley
|
2008
|
120,793 | 6,331 | 0 | 15,220 | 0 | 0 | 4,832 | 147,176 | |||||||||||||||||||||||||
Vice
President, Sales
|
2007
|
120,000 | 4,505 | 0 | 0 | 0 | 0 | 4,800 | 129,305 | |||||||||||||||||||||||||
and
Marketing
|
2006
|
100,000 | 2,472 | 0 | 0 | 0 | 0 | 4,360 | 106,832 | |||||||||||||||||||||||||
Jeffrey
A. Dahlen
|
2008
|
100,000 | 1,700 | 0 | 15,220 | 0 | 0 | 4,000 | 120,920 | |||||||||||||||||||||||||
President,
Words+, Inc.
|
2007
|
96,000 | 1,736 | 0 | 0 | 0 | 0 | 3,840 | 101,576 | |||||||||||||||||||||||||
subsidiary
|
2006*
|
n/a | n/a | n/a | 0 | 0 | 0 | 0 | n/a |
(d)
|
Amount
represents bonus earned during the applicable
year.
|
(f)
|
Amount
represents the stock-based compensation expense recorded by
us in fiscal 2008 measured using the Black-Scholes option
pricing model at the grant date based on the fair value of the
option award.
|
(i)
|
Amount
represents Company matching for 401(k)
Plan.
|
*
|
Annual
compensation less than $100,000.
|
Estimated
future payouts under
Non-equity
incentive plan awards
|
Estimated
future payouts under
Equity
incentive plan awards
|
|||||||||||||||||||||||||||||||||||
Name
|
Grant
Date
|
Threshold($)
|
Target($)
|
Maximum($)
|
Threshold($)
|
Target($)
|
Maximum($)
|
All
other stock awards. Number of shares of stock or
units(#)
|
All
other awards. Number of securities underlying
options(#)
|
|||||||||||||||||||||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i)
|
(j)
|
|||||||||||||||||||||||||||
Walter
Woltosz
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||||||||||||||||||
Momoko
Beran
|
01/21/2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
10,000 | |||||||||||||||||||||||||||
Ronald
Creeley
|
01/21/2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
5,000 | |||||||||||||||||||||||||||
Jeffrey
Dahlen
|
01/21/2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
5,000 |
Name
(a)
|
Number
of Securities underlying unexercised options
(#)
Exercisable
(b)
|
Number
of securities underlying unexercised options
(#)
Unexercisable
(c)
|
Number
of securities underlying unexercised options unearned options
(#)
(d)
|
Option
exercise price
($)
(e)
|
Option
expiration
date
(f)
|
Number
of shares or units of stock that have not vested
(g)
|
Market
value of shares or units of stock that have not vested
($)
(h)
|
Number
of unearned shares, units or other rights that have not vested
(#)
(i)
|
Equity
incentive plan awards:
Market
or payout value of unearned shares units or other rights that have not
vested ($)(j)
|
||||||||||||||||||||||||
Walter
Woltosz
|
30,000 | -0- | -0- | 1.2375 |
07/20/2011
|
-0- | -0- | -0- | -0- | ||||||||||||||||||||||||
Virginia
Woltosz
|
30,000 | -0- | -0- | 1.2375 |
07/20/2011
|
-0- | -0- | -0- | -0- | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Momoko
Beran
|
17,000 | -0- | -0- | 0.3275 |
10/30/2008
|
-0- | -0- | -0- | -0- | ||||||||||||||||||||||||
24,000 | 0.3750 |
06/16/2009
|
|||||||||||||||||||||||||||||||
160,000 | 0.5625 |
11/23/2009
|
|||||||||||||||||||||||||||||||
160,000 | 0.7500 |
04/17/2010
|
|||||||||||||||||||||||||||||||
40,000 | 0.4075 |
08/09/2010
|
|||||||||||||||||||||||||||||||
60,000 | 0.4075 |
12/01/2010
|
|||||||||||||||||||||||||||||||
140,000 | 0.3500 |
05/03/2011
|
|||||||||||||||||||||||||||||||
20,000 | 1.1050 |
06/22/2015
|
|||||||||||||||||||||||||||||||
40,000 | 1.1250 |
07/20/2016
|
|||||||||||||||||||||||||||||||
10,000 | 3.0200 |
01/21/2018
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Ronald
Creeley
|
64,000 | -0- | -0- | 0.3275 |
10/30/2008
|
-0- | -0- | -0- | -0- | ||||||||||||||||||||||||
24,000 | 0.3750 |
06/16/2009
|
|||||||||||||||||||||||||||||||
172,000 | 0.5625 |
11/23/2009
|
|||||||||||||||||||||||||||||||
160,000 | 0.7500 |
04/17/2010
|
|||||||||||||||||||||||||||||||
40,000 | 0.4075 |
08/09/2010
|
|||||||||||||||||||||||||||||||
60,000 | 0.4075 |
12/01/2010
|
|||||||||||||||||||||||||||||||
140,000 |
|
0.3500 |
05/03/2011
|
||||||||||||||||||||||||||||||
20,000 |
|
1.1050 |
06/22/2015
|
||||||||||||||||||||||||||||||
40,000 |
|
1.1250 |
07/20/2016
|
||||||||||||||||||||||||||||||
5,000 |
|
3.0200 |
01/21/2018
|
||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Jeffrey
Dahlen
|
65,000 | -0- | -0- | 1.1500 |
04/16/2014
|
-0- | -0- | -0- | -0- | ||||||||||||||||||||||||
5,000 | 3.0200 |
01/21/2018
|
BENEFICIAL
OWNER (1)(2)
|
AMOUNT
AND NATURE OF
BENEFICIAL
OWNERSHIP
|
PERCENT
OF
CLASS
|
||||||
Walter
S. and Virginia E. Woltosz (3)
|
7,371,900 | 41.05 | % | |||||
Momoko
Beran (4)
|
820,450 | 4.57 | % | |||||
Ronald
F. Creeley (5)
|
825,595 | 4.60 | % | |||||
Jeffrey
A. Dahlen (6)
|
260,000 | 1.45 | % | |||||
Dr.
David Z. D'Argenio (7)
|
26,812 | * | ||||||
Dr.
Richard R. Weiss (8)
|
26,812 | * | ||||||
H.
Wayne Rosenberger (9)
|
0 | * | ||||||
All
directors and officers as a group
|
9,331,569 | 51.96 | % |
*
|
Less
than 1%
|
(1)
|
Such
persons have sole voting and investment power with respect to all Shares
of Common Stock shown as being beneficially owned by them, subject to
community property laws, where applicable, and the information contained
in the footnotes to this table.
|
(2)
|
The
address of each director and executive officer named is c/o the Company,
42505 Tenth Street West, Lancaster, California
93534-7059.
|
(3)
|
Own
an aggregate of 7,311,900 plus 60,000 shares of common stock underlying an
option exercisable within the next 60 days of the date of this Annual
Report.
|
(4)
|
Owns
159,450 shares of common stock acquired from the exercise of options
granted under the 1996 Stock Option plan, plus 661,000 shares of common
stock underlying an option exercisable within the next 60 days of the date
of this Annual Report.
|
(5)
|
Owns
105,595 shares of common stock, plus 720,000 shares of common stock
underlying an option exercisable within the next 60 days of the date of
this Annual Report.
|
(6)
|
Owns
195,000 shares of common stock, plus 65,000 shares of common stock
underlying an option exercisable within the next 60 days of the date of
this Annual Report.
|
(7)
|
Owns
4,000 shares of common stock, plus 22,812 shares of common stock
underlying an option exercisable within the next 60 days of the date of
this Annual Report. Does not include stock options for 3,200 shares, which
are not exercisable within the next 60 days of the date of this Annual
Report.
|
(8)
|
Owns
4,000 shares of common stock, plus 22,812 shares of common stock
underlying an option exercisable within the next 60 days of the date of
this Annual Report. Does not include stock options for 3,200 shares, which
are not exercisable within the next 60 days of the date of this Annual
Report.
|
(9)
|
Does
not include stock options for 1,500 shares, which are not exercisable
within the next 60 days of this
report.
|
Name
|
No.
of
Securities
Underlying
Options
Granted
|
Percent
of
Total
Options
Granted
to
Employees
in
FY06
|
Potential
Realizable Value at
Assumed
Annual Rated of Stock
Exercise
Price
Per
Share
|
Price
Appreciation for Option
Expiration
Date
|
Term
|
||||||||||||||||
1%
|
4%
|
||||||||||||||||||||
Momoko
A. Beran
|
10,000 | 11.5 | % | $ | 3.02 |
01/21/2018
|
$ | 3,161 | $ | 14,511 | |||||||||||
Ronald
F. Creeley
|
5,000 | 5.7 | % | $ | 3.02 |
01/21/2018
|
$ | 1,567 | $ | 7,192 | |||||||||||
Jeffrey
A. Dahlen
|
5,000 | 5.7 | % | $ | 3.02 |
01/21/2018
|
$ | 1,567 | $ | 7,192 |
Shares
Acquired
on
Exercise
|
Value
Realized
(2)
|
Number
of Options at August 31, 2008
|
Value
of Options at
August
31, 2008 (1)
|
|||||||||||||||||||||
Exercisable
|
Unexercisable
|
Exercisable
|
Unexercisable
|
|||||||||||||||||||||
Walter
S. Woltosz
|
- | - | 30,000 | - | $ | 17,175 | * | $ | 0.00 | * | ||||||||||||||
Virginia
E. Woltosz
|
- | - | 30,000 | - | $ | 17,175 | * | $ | 0.00 | * | ||||||||||||||
Momoko
Beran
|
36,000 | $ | 88,590 | 661,000 | 10,000 | $ | 814,993 | $ | 0.00 | |||||||||||||||
Ronald
F. Creeley
|
60,000 | $ | 75,750 | 720,000 | 5,000 | $ | 899,640 | $ | 0.00 | |||||||||||||||
Dr.
David Z. D'Argenio
|
- | - | 20,812 | 5,600 | $ | 25,418 | $ | 852 | ||||||||||||||||
Dr.
Richard R. Weiss
|
- | - | 20,812 | 5,600 | $ | 25,418 | $ | 852 | ||||||||||||||||
Jeffrey
A. Dahlen
|
195,000 | $ | 616,150 | 65,000 | 5,000 | $ | 42,900 | $ | 0.00 | |||||||||||||||
H.
Wayne Rosenberger
|
- | - | - | 1,500 | 0 | 0 |
(1)
|
Based
on a per share price of $1.81 at August 31, 2008 less applicable option
exercise prices.
|
(2)
|
The
value realized represents the difference between the aggregate closing
price of the shares on the date of exercise less the aggregate exercise
price paid.
|
*
|
Granted
at $2.48, 110% of market price of the issue
date.
|
Fee Category
|
FY08 Fees
|
FY07 Fees
|
||||||
Audit
fees
|
$ | 74,010 | $ | 67,845 | ||||
Tax
fees
|
15,880 | 10,030 | ||||||
All
other fees
|
-- | -- | ||||||
Total fees
|
$ | 89,890 | $ | 77,875 |
By
Order of the Board of Directors
/s/
Virginia E.
Woltosz
Virginia
E. Woltosz
Secretary
Dated:
January 22,
2009
|
·
|
Review
and recommend to the management the independent auditors to be selected to
audit the financial statements of the corporation and its
subsidiaries.
|
·
|
Review
with the independent auditors, the company's management, and financial and
accounting personnel, the adequacy and effectiveness of the accounting and
financial controls of the corporation, and elicit
any recommendations for the improvement of such internal
control procedures or particular areas where new or more detailed controls
or procedures are desirable. Particular emphasis should be given to the
adequacy of such internal controls to expose any payments, transactions,
or procedures that might be deemed illegal or otherwise improper. Further,
the committee periodically should review company
policy.
|
·
|
Review
the financial statements contained in the annual report to shareholders
with management and the independent auditors to determine that the
independent auditors are satisfied with the disclosure and content of the
financial statements to be presented to the shareholders. Any changes in
accounting principles should be
reviewed.
|
·
|
Provide
sufficient opportunity for independent auditors to meet with the members
of the audit committee without members of management present. Among the
items to be discussed in these meetings are the independent auditors'
evaluation of the corporation's financial, accounting, auditing personnel,
and the cooperation that the independent auditors received during the
course of the audit.
|
·
|
Investigate
any matter brought to its attention within the scope of its duties, with
the power to retain outside counsel for this purpose if,
in its judgment, that is
appropriate.
|
FOR
[_]
|
WITHHELD
[_]
|
|
FOR
all nominees except as stated on line
above
|
FOR
[_]
|
AGAINST
[_]
|
ABSTAIN
[_]
|